Search results
Shark Tank fame Namita Thapar likely to make around Rs 127 crore through Emcure Pharmaceuticals IPO...
The Times of India· 6 days agoNamita Thapar, a promoter group member of Emcure Pharmaceuticals and known for her appearance on ...
Emcure Pharmaceuticals IPO: Shark Tank’s Namita Thapar likely to earn ₹127 crore from OFS | Stock...
Livemint· 5 days agoEmcure Pharmaceuticals IPO set to start tomorrow estimated to bring in ₹127.87 crore for Namita...
Shark Tank's Namita Thapar to make 293x on her Emcure Pharma exit
CNBC Awaaz· 6 days agoAt the upper end of the price band, Thapar will achieve a 293-fold return. The price band for Emcure...
A New Ray of Hope: Cannazo India's Breakthrough in Medical Cannabis for Multiple Sclerosis on Shark ...
SiliconIndia· 6 days agoIn 2023, the Asia-Pacific region (which includes India) contributed to 33% of the global hemp...
Namita Thapar-backed Emcure Pharma IPO kicks off: Should you subscribe to the issue?
Business Today· 4 days agoThe Shark Tank India fame Namita Thapar-backed company is offering its shares in the range of Rs...
Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details
The Economic Times· 2 days agoThe initial public offer (IPO) of Emcure Pharmaceuticals was booked over 13 times so far on the...
Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of...
The Economic Times· 5 days agoThe initial public offering (IPO) of Emcure Pharmaceuticals will open for subscription on Wednesday,...
Emcure Pharma IPO to open on July 3, Shark Namita Thapar likely to earn ₹127 crore - CNBC TV18
CNBC TV18· 5 days agoThe initial share sale of Pune-based Emcure Pharmaceuticals will open for public subscription on...
Lava banks on product quality, after-sales to boost smartphone market share
Financial Express· 2 days agoLava looks to raise Rs 500 crore via private equity before IPO.
Emcure Pharma IPO: GMP surges on last day; issue subscribed 24 times so far - CNBC TV18
CNBC TV18· 2 days agoThe initial share sale of Emcure Pharmaceuticals was off to a strong start on the last day of the...